Free tool
FAERS Monitor: Diuril
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 011145 or its brand name (Diuril, Chlorothiazide, Chlorothiazide Sodium). Reports on generic versions are filed under their own applications.
Reports
1,263
Serious
1,011
80% of reports
Hospitalization
635
Death reported
199
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use88
- dyspnoea81
- pyrexia79
- diarrhoea73
- hypotension71
- drug ineffective66
- pneumonia63
- respiratory failure62
- pain59
- vomiting52
- death50
- cough48
- headache48
- renal failure45
- condition aggravated42
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 19 |
| 2005 | 25 |
| 2006 | 19 |
| 2007 | 25 |
| 2008 | 16 |
| 2009 | 27 |
| 2010 | 35 |
| 2011 | 55 |
| 2012 | 40 |
| 2013 | 53 |
| 2014 | 56 |
| 2015 | 55 |
| 2016 | 84 |
| 2017 | 63 |
| 2018 | 120 |
| 2019 | 107 |
| 2020 | 108 |
| 2021 | 92 |
| 2022 | 93 |
| 2023 | 61 |
| 2024 | 43 |
| 2025 | 41 |
| 2026 | 26 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,896 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| respiratory failureSignal | 62 | 14.2 | 11.1 | 748 |
| hypotensionSignal | 71 | 5.9 | 4.7 | 286 |
| renal failureSignal | 45 | 5.6 | 4.2 | 168 |
| pyrexiaSignal | 79 | 3.8 | 3.1 | 163 |
| pneumoniaSignal | 63 | 3.2 | 2.5 | 97 |
| coughSignal | 48 | 2.9 | 2.2 | 57 |
| dyspnoeaSignal | 81 | 2.4 | 1.9 | 65 |
| condition aggravatedSignal | 42 | 2.3 | 1.7 | 30 |
| diarrhoea | 73 | 1.9 | 1.5 | 30 |
| vomiting | 52 | 1.8 | 1.4 | 20 |
| off label use | 88 | 1.7 | 1.4 | 24 |
| pain | 59 | 1.6 | 1.2 | 13 |
| headache | 48 | 1.3 | 1.0 | 3 |
| death | 50 | 1.0 | 0.7 | 0 |
| drug ineffective | 66 | 0.8 | 0.7 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.